Navigation Links
BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
Date:9/5/2007

MORRISVILLE, N.C.--(BUSINESS WIRE) September 5, 2007 BioDelivery Sciences International, Inc. (Nasdaq: BDSI) has entered into an exclusive and perpetual license and related supply agreement with Meda for the U.S., Canadian and Mexican commercialization rights to BDSIs flagship BEMATM Fentanyl product for the treatment of breakthrough cancer pain. Under this agreement, Meda will be responsible for the marketing and distribution of BEMA Fentanyl in the U.S., whose launch is anticipated in late 2008. In addition, Meda will be responsible for the management of the post-NDA approval clinical development program.

Financial Aspects of the Partnership:

  • 1st milestone: $30 million upon closing which is contingent upon antitrust approval by the Federal Trade Commission, which typically occurs within 30 days of filing.

  • 2nd milestone: $30 million upon receipt of FDA approval, which is anticipated in late 2008.

  • Royalty: BDSI to receive a significant double digit royalty on net sales. Guaranteed minimum annual royalties, based on low sales, exist during the first 7 years.

  • Sales milestones: A total of $30 million payable at:
    • $10 million when annualized sales exceeds $75 million
    • $10 million when annualized sales exceeds $125 million
    • $10 million when annualized sales exceeds $175 million
  • A gross margin above 70% is secured for Meda.

BEMA Fentanyl consists of a small, dissolvable, polymer disc, formulated with the opioid narcotic fentanyl, for application to the buccal (inner lining of cheek) membranes. BEMA Fentanyl has shown in clinical studies important patient advantages compared to competing products, especially fewer side effects. According to published results, the two currently largest competing fentanyl products in the U.S. with the same indication had combined sales of nearly $700 million in 2006 and grew by approximately 60% versus 2005.


'/>"/>
Contact: Bill Douglass
bdouglass@investorrelationsgroup.com
212-825-3210
BioDelivery Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. TV drug commercials prompt prescriptions
2. Commercialization of Biotech Discoveries, An Encouragement For Researchers
3. A Move To Help Commercial Sex Workers Quit Their Business
4. Commercial grape juices and vinegars found rich in antioxidants
5. Widespread Commercialisation Of Human Organ Donation In China
6. Commercialization of drugs by fast tracking is a cause of concern
7. Formula milk suffering due to commercial interests
8. Spine Gourd Variety Helpful For Diabetics Is Ready For Commercial Cultivation
9. Updated Sleep Apnea Screening Recommended for Commercial Drivers
10. The Psyche Behind Drug Commercials
11. Magnets in Commercial Products may Cause a Fatal Attraction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... , ... Healthpointe is proud to welcome Dr. Ted Priebe, O.M.D., CEO of ... practice Chinese Needle Therapy since 1983, Dr. Priebe specializes in the study and treatment ... in Healthpointe’s La Mirada clinic and Garden Grove clinic. , Acupuncture ...
(Date:8/27/2015)... ... ... In addition to its existing Doctor of Philosophy in Leadership and Doctor of ... campus in Reading: Doctor of Nursing Practice. , Alvernia’s Doctor of Nursing Practice ... the highest level of clinical nursing practice. , “Our vision is to graduate ...
(Date:8/27/2015)... ... August 27, 2015 , ... For the first ... machine with the Nutri Ninja® Auto-iQ Pro Complete and Nutri Ninja Auto-iQ Compact ... that takes drink customization to a whole new level. This line of Nutri ...
(Date:8/27/2015)... ... ... Susan Harris and the team at LifeStream Health Centre & ... post-menopause, chemotherapy, and child birth. , The MonaLisa Touch is a unique ... tissue, revitalizing cells so they make more collagen, an essential component in vaginal cell ...
(Date:8/27/2015)... ... 27, 2015 , ... Since its launch on August 16, ... offices in three counties, LA, Orange and San Bernardino. Their twenty physicians ... by Dr. Richy Agajanian, the Oncology Institute of Hope and Innovation is dedicated ...
Breaking Medicine News(10 mins):Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 3Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 4Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 2Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 3Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2
... of a naturally occurring fat molecule have the potential ... or damage, researchers report. , Through both the ... smooth, young skin inevitably becomes coarse and wrinkled. The ... both lower the production of new collagen while increasing ...
... percent of patients who recently underwent liver transplantation ... factors included having had biliary-enteric anastomosis (choledocho-jejunal or ... more than four red blood cell units transfused. ... of Liver Transplantation, a journal by John Wiley ...
... internet pharmacies and life-saving medicines, purchased online was ... Global Forum ... June 5 The European Alliance for Access ... research report,-- The Counterfeiting Superhighway. The report revealed ...
... Reps. Pomeroy, Capito, Berkley Leading,Respective Chambers, Letter Effort ... to Seniors, Medicare-Financed Nursing Home Care, WASHINGTON, ... and Alliance for Quality Nursing Home Care today ... and Reps. Earl,Pomeroy (D-ND), Shelley Moore Capito (R-WV) ...
... June 5 Fort Dodge Animal Health, a,division of ... of,ProHeart(R) 6, a unique heartworm preventative, to the U.S. ... Food and Drug,Administration,s Center for Veterinary Medicine (CVM) of ... support the decision,to return this life-saving product to the ...
... to restore function to a paralyzed limb? Or to ... are two of the several topics that will be ... by Case Western Reserve University. The conference will be ... Conference Center in Cleveland. , "Neural interfaces have already ...
Cached Medicine News:Health News:Researchers determine risk factors for infection after liver transplantation 2Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 2Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 3Health News:AHCA, Alliance Praise New Bipartisan, Bi-Cameral Effort Urging Bush Administration to Forego Medicare Cuts 2Health News:AHCA, Alliance Praise New Bipartisan, Bi-Cameral Effort Urging Bush Administration to Forego Medicare Cuts 3Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 2Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 3Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 4Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 5Health News:Premier conference on neurotechnology and deep brain stimulation to be held in Cleveland June 16-18 2
(Date:8/27/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ... therapies, today announced that it will release its year-end ... 2015 on Friday, September 4, 2015. ... call and live webcast for investors, analysts and other ...
(Date:8/27/2015)... , Spain and CAMBRIDGE, Mass. , Aug. ... be presenting at the Rodman & Renshaw 17th Annual Global ... Held at the St. Regis Hotel, ORYZON will be represented ... Dr. Buesa will present ... EDT, at the Fontainebleau Room (2nd Floor).  The company is ...
(Date:8/27/2015)... 2015 The global compression ... 3.96 billion by 2022, according to a new report ... venous disorders such as deep vein thrombosis, leg ulcers, ... the key driver.      (Logo: http://photos.prnewswire.com/prnh/20150105/723757) , ... also expected to boost market growth over the forecast ...
Breaking Medicine Technology:DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 2DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 4Compression Therapy Market To Reach $3.96 Billion By 2022: Grand View Research, Inc. 2Compression Therapy Market To Reach $3.96 Billion By 2022: Grand View Research, Inc. 3Compression Therapy Market To Reach $3.96 Billion By 2022: Grand View Research, Inc. 4Compression Therapy Market To Reach $3.96 Billion By 2022: Grand View Research, Inc. 5
... Mass., Jan. 23, 2012  Boston Scientific Corporation (NYSE: ... District of New Jersey has found all the asserted patents ... invalid and entered judgment in favor of Boston Scientific. ... Johnson alleged that Boston Scientific,s PROMUS® Everolimus-Eluting Coronary Stent System ...
... Premier Research Group announces the appointment of Etienne Drouet ... this position, Mr. Drouet will play a leading role ... Premier Research,s growing portfolio of oncology business. ... oncology acumen serving the needs of our customers," said ...
Cached Medicine Technology:Boston Scientific Announces Favorable Ruling in Patent Infringement Case 2Boston Scientific Announces Favorable Ruling in Patent Infringement Case 3Premier Research Names Etienne Drouet Executive Director, Oncology Europe 2
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
... Consensus knee system continues the "Consensus Concept" ... with the diversified experience of a Scientific ... knee system that incorporates state-of-the-art features. Consensus ... joint and implant stability and allow near ...
Profix total knee system is intended for cemented use only....
Medicine Products: